Literature DB >> 24210117

Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Zhilong Yang1, Liliana Maruri-Avidal, Jerry Sisler, Carey A Stuart, Bernard Moss.   

Abstract

Vaccinia virus contains ~200 genes classified temporally as early, intermediate or late. We analyzed 53 intermediate promoters to determine whether any have dual late promoter activity. Our strategy involved (i) construction of a cell line that stably expressed the three late transcription factors, (ii) infection with a vaccinia virus mutant that expresses RNA polymerase but neither intermediate nor late transcription factors, and (iii) transfection with plasmids containing a luciferase reporter regulated by an intermediate promoter. After confirming the specificity of the system for late promoters, we found that many intermediate promoters had late promoter activity, the strength of which correlated with a TAAAT at the initiator site and T-content from positions -12 to -8 of the coding strand. In contrast, intermediate promoter activity correlated with the A-content from positions -22 to -14. The sequence correlations were confirmed by altering the specificities of strict intermediate and late promoters. Published by Elsevier Inc.

Entities:  

Keywords:  Consensus promoter sequence; Poxvirus transcription; Regulation of gene expression; mRNA Synthesis

Mesh:

Year:  2013        PMID: 24210117      PMCID: PMC3840034          DOI: 10.1016/j.virol.2013.09.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Targeting of proteins derived from self-processing polyproteins containing multiple signal sequences.

Authors:  Pablo de Felipe; Martin D Ryan
Journal:  Traffic       Date:  2004-08       Impact factor: 6.215

3.  Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.

Authors:  J L Rosel; P L Earl; J P Weir; B Moss
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  Structure of vaccinia virus late promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

5.  In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals.

Authors:  M A Cochran; C Puckett; B Moss
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

6.  Vaccinia virus gene encoding a component of the viral early transcription factor.

Authors:  S S Broyles; B S Fesler
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  Biochemical and biophysical properties of a putative hub protein expressed by vaccinia virus.

Authors:  Nicole E Kay; Travis W Bainbridge; Richard C Condit; Michael R Bubb; Reuben E Judd; Balasubramanian Venkatakrishnan; Robert McKenna; Susan M D'Costa
Journal:  J Biol Chem       Date:  2013-03-08       Impact factor: 5.157

8.  One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription.

Authors:  C Bertholet; R Drillien; R Wittek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  Purification of a factor required for transcription of vaccinia virus early genes.

Authors:  S S Broyles; L Yuen; S Shuman; B Moss
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

10.  Derepression of a novel class of vaccinia virus genes upon DNA replication.

Authors:  J C Vos; H G Stunnenberg
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  17 in total

1.  Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling.

Authors:  Zhilong Yang; Shuai Cao; Craig A Martens; Stephen F Porcella; Zhi Xie; Ming Ma; Ben Shen; Bernard Moss
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  Simultaneous Quantification of Viral Antigen Expression Kinetics Using Data-Independent (DIA) Mass Spectrometry.

Authors:  Nathan P Croft; Danielle A de Verteuil; Stewart A Smith; Yik Chun Wong; Ralf B Schittenhelm; David C Tscharke; Anthony W Purcell
Journal:  Mol Cell Proteomics       Date:  2015-03-09       Impact factor: 5.911

3.  Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.

Authors:  Nicole Shepherd; Jie Lan; Wei Li; Sushmita Rane; Qigui Yu
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

5.  Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.

Authors:  Steven J Conrad; Jia Liu
Journal:  Methods Mol Biol       Date:  2019

6.  Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox.

Authors:  Tiffany R Frey; Katherine S Forsyth; Maura M Sheehan; Brian C De Haven; Julia G Pevarnik; Erin S Hand; Marie C Pizzorno; Laurence C Eisenlohr; Adam R Hersperger
Journal:  Virology       Date:  2018-03-27       Impact factor: 3.616

7.  Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation Inhibition.

Authors:  Gilad Sivan; Shira G Glushakow-Smith; George C Katsafanas; Jeffrey L Americo; Bernard Moss
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 8.  Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges.

Authors:  Shyambabu Chaurasiya; Yuman Fong; Susanne G Warner
Journal:  Cancers (Basel)       Date:  2020-06-26       Impact factor: 6.639

9.  Mucosal and Systemic Immune Responses to Salmon Gill Poxvirus Infection in Atlantic Salmon Are Modulated Upon Hydrocortisone Injection.

Authors:  Marit M Amundsen; Haitham Tartor; Kathrine Andersen; Karoline Sveinsson; Even Thoen; Mona C Gjessing; Maria K Dahle
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

10.  Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions.

Authors:  Cornelia Barnowski; Gregor Ciupka; Ronny Tao; Lei Jin; Dirk H Busch; Sha Tao; Ingo Drexler
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.